CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sharon Bio-Medicine Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sharon Bio-Medicine Ltd
601
Proxima, Plot No 19, Sector 30A, Vashi
Phone: +91 2267944000p:+91 2267944000 NAVI MUMBAI, 400705  India Ticker: SHARONBIOSHARONBIO
This company is no longer actively traded on any major stock exchange.
Business Summary
Sharon Bio-Medicine Limited is an India-based pharmaceutical company. The Company is engaged in providing a range of pharmaceutical products and services, including animal toxicology and manufacturing of finished dosages. The Company's products include active pharma ingredients (APIs) and intermediates, and formulations. Its APIs and intermediates include Ketoconazole, Miconazole Nitrate, Sertaconazole Nitrate, Trimetazidine Di HCl, Nifedipine, Atomoxetine HCl, Trazodone HCl, Memantine HCI, Eperisone HCl, Glimepiride, Mosapride Citrate Dihydrate and Aripiprazole. Its formulation includes Aripiprazole tablets, Atorvastatin tablets, Azithromycin tablets, Betahistine tablets, Carbimazole tablets, Celecoxib capsules, Clopidogrel tablets, Carbocisteine capsules, Enalapril Maleate tablets, Donepezil tablets, Ezetimibe tablets and Famciclovir tablets. Its manufacturing facility is located at Navi Mumbai.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20233/31/2016Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer KaushikBanerjee 5/24/2018 5/24/2018
Compliance Officer, Company Secretary RakhiMakhloga 1/23/2023 1/23/2023

Business Names
Business Name
532908
M/s. Stonewood Cem-Fab (India) Pvt. Ltd.
SHARONBIO

General Information
Outstanding Shares: 5,755,625 (As of 3/31/2023)
Shareholders: 27,331
Stock Exchange: NSE
Fax Number: +91 2267944001


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024